These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8466083)

  • 1. Potency versus onset of neuromuscular blocking agents.
    Gyermek L
    Anesthesiology; 1993 Apr; 78(4):795-7. PubMed ID: 8466083
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure, conformation, and action of neuromuscular blocking drugs.
    Lee C
    Br J Anaesth; 2001 Nov; 87(5):755-69. PubMed ID: 11878528
    [No Abstract]   [Full Text] [Related]  

  • 3. 3,16-Bisquaternary ammonium steroid derivatives as neuromuscular blocking agents: synthesis and biological evaluation.
    Hu H; Rao Z; Feng M; Wu Z; Xu J; Chen H; Liu P; Xiao Y; Hong X; Hu X; Ke X
    Steroids; 2015 Apr; 96():103-14. PubMed ID: 25637675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to short-acting neuromuscular blocking agents: nonsymmetrical bis-tetrahydroisoquinolinium mono- and diesters.
    Dhar NC; Maehr RB; Masterson LA; Midgley JM; Stenlake JB; Wastila WB
    J Med Chem; 1996 Jan; 39(2):556-61. PubMed ID: 8558527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blocking drugs and renal failure.
    Pollard BJ
    Br J Anaesth; 1992 Jun; 68(6):545-7. PubMed ID: 1535206
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypothermia and the action of neuromuscular blocking agents.
    Mazala M; Horrow JC; Storella RJ
    Anaesthesia; 1988 Feb; 43(2):162. PubMed ID: 3354819
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuromuscular blocking drugs.
    Bevan DR
    Can Anaesth Soc J; 1983 May; 30(3 Pt 2):S56-61. PubMed ID: 6400756
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuromuscular block.
    Feldman S
    Anaesth Intensive Care; 1997 Jun; 25(3):313-4. PubMed ID: 9209625
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and neuromuscular blocking activity of 16-(2- and 3-pyridylmethylene) dehydroepiandrosterone derivatives.
    Dubey S; Sharma AK; Jindal DP; Harvey A; Singh R; Bodhankar SL
    Steroids; 2010 Apr; 75(4-5):323-9. PubMed ID: 20097219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat.
    Bowman WC; Rodger IW; Houston J; Marshall RJ; McIndewar I
    Anesthesiology; 1988 Jul; 69(1):57-62. PubMed ID: 2898902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new neuromuscular blocking agents: do they offer any advantages?
    Moore EW; Hunter JM
    Br J Anaesth; 2001 Dec; 87(6):912-25. PubMed ID: 11878696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in neuromuscular blocking agents.
    Bartkowski RR
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S14-7. PubMed ID: 10437712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect sites of neuromuscular blocking agents and the monitoring of clinical muscle relaxation.
    Meistelman C
    Adv Exp Med Biol; 2003; 523():227-38. PubMed ID: 15088854
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology of neuromuscular blocking agents in the intensive care unit.
    Hanson CW
    Crit Care Clin; 1994 Oct; 10(4):779-97. PubMed ID: 8000926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent clinical advance of rocuronium pharmacokinetics and a new neuromuscular reversal agent, sugammadex].
    Iwasaki H
    Hokkaido Igaku Zasshi; 2012 Aug; 87(4-5):133-5. PubMed ID: 23236656
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuromuscular blockade in the elderly.
    Stankiewicz-Rudnicki M
    Anaesthesiol Intensive Ther; 2016; 48(4):257-260. PubMed ID: 27797097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of neuromuscular blocking drugs.
    Cammu G
    Acta Anaesthesiol Belg; 2001; 52(4):357-63. PubMed ID: 11799568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical properties of neuromuscular blocking agents and their impact on the pharmacokinetic-pharmacodynamic relationship.
    Roy JJ; Varin F
    Br J Anaesth; 2004 Aug; 93(2):241-8. PubMed ID: 15169739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An isolated, antegrade, perfused, peroneal nerve anterior tibialis muscle model in the rat: a novel model developed to study the factors governing the time course of action of neuromuscular blocking agents.
    De Haes A; Houwertjes MC; Proost JH; Wierda JM
    Anesthesiology; 2002 Apr; 96(4):963-70. PubMed ID: 11964606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular blockers in patients with burns.
    Lancet; 1988 Oct; 2(8618):1003-4. PubMed ID: 2902437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.